Financial Planning and Analysis Analyst
About the job
- An undergraduate degree in a finance-related field, either Finance or Accounting.
- A minimum of 3 years of prior experience in FP&A and/or Commercial Finance within the pharmaceutical or medical device industry.
- Experience working within a matrix, multinational corporation environment.
- Excellent Excel skills, including macros, PowerPoint proficiency, and familiarity with Microsoft applications and SAP.
- Experience with SAP, SAP BPC planning tool, and Power BI.
- Ability to speak English proficiently.
- Ability to manage multiple stakeholders across all organizational levels and manage large datasets and multiple priorities efficiently.
- Ability to understand time-sensitive matters and deliver on time.
- Ability to learn new concepts and adapt to new ways of working.
- Consolidate input from multiple stakeholders and support uploading data into financial systems for actuals, demand statements, and forecasting cycles.
- Prepare local financial reports and reporting deliverables for Region South, Europe Area, and Global.
- Prepare and maintain dashboards that provide real-time data, and communicate business results through reports, variance analysis, and commentaries to management, Region South, Europe Area, and Global.
- Monitor and control affiliate-wide departmental budgets and expenses.
- Support expense forecasting and upload data into financial systems.
- Prepare ad hoc journal entries to ensure accurate expense reporting.
- Prepare and maintain monthly reports and dashboards showing expense spending by department, IOs, general ledger accounts, and activity for the affiliate.
- Analyze expenses to support accurate forecasting and landing, and prepare commentaries on variances against benchmarks.
- Prepare and support affiliate Product P&L reporting.
- Perform ad hoc analyses to understand spending trends.
- Prepare reporting deliverables for monthly S&OP and ad hoc meetings requiring financial information.
- Maintain ad hoc dashboards and reports to provide real-time data.
- Support business case preparation and internal-controls compliance.
- Identify trends, challenge forecasts, and validate and monitor assumptions for each brand.
- Perform ad hoc analysis and forecasting for internal management and external customers to support business initiatives and decisions.
- Lead improvement projects related to financial reporting, financial systems, and processes.
- Participate in, lead, and manage projects assigned by Europe Area or Global.
- Experience with RPA and artificial intelligence.
About the company
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Company Size
10,001+
Company Stage
IPO
Headquarters
North Chicago, Illinois
Founded
1888
Get referred to AbbVie
See people who can refer or advise you
Simplify's Take
What believers are saying
- Apogee acquisition closed in 2026, expanding AbbVie’s immunology pipeline beyond Skyrizi and Rinvoq.
- EU approvals for RINVOQ and EPKINLY in September 2026 broaden ex-U.S. revenue.
- JUVMO launches in October 2026, adding a fresh neuroscience revenue line.
What critics are saying
- Humira, Skyrizi, and Rinvoq concentration keeps AbbVie exposed if immunology growth slows in 2027.
- Niaspan antitrust MDL and Biocell ALCL settlements carried $1.7 billion litigation accrual by June 2026.
- Generic ubrogepant and atogepant suits threaten Ubrelvy and Qulipta exclusivity within years.
What makes AbbVie unique
- Skyrizi and Rinvoq anchor AbbVie’s post-Humira immunology franchise across 11 EU RINVOQ indications.
- JUVMO’s September 28, 2026 FDA approval gives AbbVie first-in-class Parkinson’s D1/D5 therapy.
- AbbVie pairs blockbuster cash flows with Apogee, Iambic, and Valkai deal-making.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Remote Work Options
- Flexible Work Hours
- Professional Development Budget